BLOG/🇺🇸United States··daily

US SEC Filings Daily Market Digest — March 27, 2026

Daily USA Market Intelligence

28 high priority22 medium priority50 total filings analysed

Executive Summary

The March 27, 2026, SEC filings digest reveals a dominant proxy season theme with 15+ DEFA14A/DEF 14A filings for May 2026 AGMs across sectors like airlines (Southwest, Murphy Oil), pharma (Indivior, Nurix), and metals (Trilogy), signaling routine governance but highlighting positive 2025 recaps (e.g., Indivior revenue +4% YoY to $1.24B, Murphy Oil production +3% YoY to 182 MBOEPD). 10-Ks show stark mixed performance: revenue growth in Sportradar (+17% YoY to €1.29B), BitGo (+424% to $16.2B), but declines in Luminar (-12% YoY to $66M), Phunware (-20% YoY to $2.6M), and SpringBig (-7% YoY to $22.8M), with margin expansions in Indivior (+500 bps to 35%) offset by compressions elsewhere. Biotech shines with Kodiak's Phase 3 GLOW2 success and Nurix's 83% ORR, while credit funds (Oaktree, Blue Owl) maintain stable leverage (0.57x-0.82x) and distributions ($0.0748/share monthly). SPACs/blank checks (BHAV, AltEnergy) report IPOs and leadership changes, and capital allocation favors returns (Indivior $400M buyback, News Corp $1B repurchase). Overall, portfolio trends indicate resilient credit/income strategies amid tech/autonomy weakness, with May AGMs as key catalysts for comp votes and auditor ratifications.

Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from March 25, 2026.

Investment Signals(12)

  • Total net revenue +4% YoY to $1.24B, SUBLOCADE +13% to $856M record, Adjusted EBITDA +20% to $428M with +500 bps margin to 35%, $400M share repurchase authorized

  • Revenue +17% YoY to €1.29B, Adjusted EBITDA +33% to €297M, profit from ops +194% to €100M (7.8% margin vs 3.0%)

  • Bexobrutideg 83% ORR/22.1-mo PFS in CLL Phase 1b, $592.9M cash post-$250M raise, $84M collab revenue, up to $6.1B milestones

  • Phase 3 GLOW2 topline superiority of Zenkuda over sham in diabetic retinopathy

  • IPO $100M gross proceeds at $10/unit + $2M private, $101M trust at $10/share

  • Production +3% YoY to 182 MBOEPD (vs 177), LOE/BOE -20% to $10.89, 103% reserve replacement, $286M shareholder returns

  • $30M equity line over 24-mo, issued 3M commitment shares for access

  • $0.16 gross March distro (net $0.144-$0.16), NAV $22.64 (-1% MoM), leverage 0.57x stable

  • $20.7M private shares sold, net leverage 0.80x, 87.8% first-lien portfolio

  • $19.9M private shares, $0.0748 gross monthly distro thru May 2026, net leverage 0.82x

  • Revenue +424% YoY to $16.2B on digital assets sales, Adj EBITDA +904% to $32M positive

  • $1M equity financing (1.25M units at $0.80), option for +$1.5M, warrants at $1.10

Risk Flags(10)

  • Revenue -12% YoY to $66M, gross loss -204% to -$78M, net loss -34% to -$366M, cash -76% to $20M, assets -64% to $131M

  • Phunware Inc.[HIGH RISK]

    Revenue -20% YoY to $2.6M (adv -78%), op ex +42% to $21.8M, net loss to -$11.4M, backlog -37% to $2.3M

  • Revenue -7% YoY to $22.8M, clients -15% to 775, NRR -10pp to 79%, Adj EBITDA -36% to $0.9M, working capital deficiency

  • Customer NRR -18pp to 109% YoY, high debt service needs, litigation costs +940% to €35M

  • Kopin Corp[MEDIUM RISK]

    Q4 rev -42% YoY to $8.4M (product -56%), reliant on defense orders delayed by govt shutdown

  • Murphy Oil Corp[MEDIUM RISK]

    Expl wells 2/3 non-commercial in Côte d’Ivoire, prod growth modest +3% YoY

  • Traeger Inc.[MEDIUM RISK]

    2025 incentive goals unmet (zero NEO payout), discretionary bonuses only amid retention push

  • Cyngn Inc.[HIGH RISK]

    Revenue -40% YoY to $0.2M, op loss to -$25.7M, shares out +4,000% to 8M diluting EPS

  • FG Nexus Inc.[HIGH RISK]

    Net loss +179% to -$68M on $38M unrealized ETH loss, G&A +54%, cash ops use +69%

  • CFO/Director resignation citing health, CEO assumes interim CFO

Opportunities(10)

Sector Themes(6)

  • Proxy Season Surge

    15+ filings (DEFA14A/DEF 14A) for May 13 AGMs (Indivior, Murphy, Trilogy), routine FOR recs on directors/comp/auditors, low materiality but watch say-on-pay votes [Governance Stability]

  • Biotech Clinical Momentum

    3/50 show strong data (Nurix 83% ORR, Kodiak Phase 3 win, Indivior SUBLOCADE +13%), contrasts mixed 10-Ks, potential Phase 3/FDA catalysts 2026 [Growth Outlier]

  • Credit Funds Resilience

    4 funds (Oaktree, Blue Owl x2, Apollo) report stable leverage 0.57x-0.82x, monthly distros $0.07-$0.16, $20B+ portfolios 85%+ first-lien, ongoing $5B+ offerings [Income Haven]

  • SPAC/Blank Check Activity

    7 filings (BHAV IPO $100M, AltEnergy/Republic/Galata/Launch 10-Ks with $10.1-$10.6 redemptions, Cartesian amendment), trust growth 4% YoY but deficits $5M-$11M [Deal Pipeline]

  • Revenue Declines in Tech/Autonomy

    5/10 10-Ks down (Luminar -12%, Phunware -20%, Cyngn -40%, Kopin Q4 -42%, SpringBig -7%), margins mixed (+/-), cash burn high [Caution Zone]

  • Capital Returns Focus

    Indivior $400M buyback, News Corp $1B repurchase, Murphy $286M returns, Oaktree/Blue Owl distros, vs reinvestment in biotech [Shareholder Friendly]

Watch List(8)

  • Multiple AGMs (Indivior, Murphy Oil, Southwest, Trilogy, Nurix)
    👁

    May 7-15 2026 virtual/hybrid votes on directors, say-on-pay (1-yr freq), auditors; track comp approval amid 2025 recaps [May 2026]

  • Potential business combination press Mar 26, monitor M&A terms/valuation update [Ongoing]

  • Phase 3 DR data Mar 26, watch full results/regulatory next steps [Q2 2026]

  • Transition Mar 31, AI/cloud focus post-Northern Data, earnings for guidance [Apr 2026]

  • Leslie's AGM Outcomes
    👁

    Rejected supermajority removal Mar 24, monitor governance shifts post-mixed votes [Ongoing]

  • 1:5 effective Mar 25, Nasdaq compliance, price stabilization [Apr 2026]

  • JV/IP deal to Apr 22, exclusivity holds [Apr 22 2026]

  • PetVivo Financing
    👁

    $600k balance by Apr 15, +$1.5M option by Jun 30 [Apr-Jun 2026]

Filing Analyses(50)
One World Products, Inc.8-Kneutralmateriality 6/10

27-03-2026

On March 24, 2026, William P. Rowland resigned from the Board of Directors, including all committees, and as Interim Chief Financial Officer of One World Products, Inc., citing ongoing health issues with no disagreements on operations, policies, or practices. Isiah L. Thomas, III, the Company's CEO, has assumed the CFO duties on an interim basis until a successor is appointed. The 8-K was filed on March 27, 2026, including the resignation letter as Exhibit 17.1.

  • ·Resignation effective March 24, 2026 (earliest event reported).
  • ·Company address: 6605 Grand Montecito Pkwy, Suite 100, Las Vegas, Nevada 89149.
  • ·Commission file number: 000-56151; I.R.S. Employer Identification No.: 61-1744826.
Trilogy Metals Inc.DEFA14Aneutralmateriality 3/10

27-03-2026

Trilogy Metals Inc. filed DEFA14A definitive additional proxy materials on March 27, 2026, notifying shareholders of the availability of proxy materials online for the Annual General Meeting on May 13, 2026, at 10:00 am Pacific Time in Vancouver, BC. The meeting agenda includes voting on the election of directors, appointment of auditors, and a non-binding advisory vote on executive compensation. No annual financial statements are included in the mailing.

  • ·Paper copy requests must be received by May 1, 2026
  • ·Meeting location: Suite 901 – 510 Burrard Street, Vancouver, British Columbia
  • ·Proxy materials available at: https://trilogymetals.com/investors/proxy-circular/ or www.sedarplus.ca
  • ·Toll-free numbers for paper requests: 1-866-962-0498 (15-digit control) or 1-855-638-8088 (16-digit control)
INDIVIOR PLCDEFA14Aneutralmateriality 7/10

27-03-2026

Indivior Pharmaceuticals, Inc. has filed definitive additional proxy materials for its 2026 Annual Meeting on May 13, 2026, at 10:00 a.m. ET virtually via www.virtualshareholdermeeting.com/INDV2026. Key proposals include the election of eight director nominees (board recommends FOR all), an advisory vote to approve named executive officer compensation (FOR), preferred frequency of say-on-pay votes (1 Year), and ratification of PricewaterhouseCoopers LLP (US) as independent auditor for FY ending December 31, 2026 (FOR). No financial metrics or performance comparisons are provided in this notice.

  • ·Vote by May 12, 2026 11:59 PM ET at www.ProxyVote.com
  • ·Request proxy materials by April 29, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
  • ·Control numbers: V88256-P50034, V88257-P50034
MURPHY OIL CORPDEFA14Apositivemateriality 7/10

27-03-2026

Murphy Oil Corporation (MUR) has filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting scheduled for May 13, 2026, at its Houston headquarters. Key proposals include the election of 10 director nominees (all Board-recommended FOR), an advisory vote to approve executive compensation (FOR), approval of the proposed 2026 Stock Plan for Non-Employee Directors (FOR), and ratification of KPMG LLP as the independent registered public accounting firm for 2026 (FOR). Shareholders must vote by May 12, 2026, 11:59 PM ET (or May 11 for plan shares), with proxy materials available online or requestable in paper/email by April 29, 2026.

  • ·Filing date: March 27, 2026
  • ·Annual Meeting address: 9805 KATY FREEWAY, SUITE G-200, HOUSTON, TEXAS 77024
  • ·Proxy materials request methods: www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com (include control number)
  • ·Vote online at: www.ProxyVote.com
SOUTHWEST AIRLINES CODEFA14Aneutralmateriality 5/10

27-03-2026

Southwest Airlines Co. (LUV) filed DEFA14A additional proxy materials for its 2026 Annual Meeting on May 7, 2026, at 4:00 p.m. CDT virtually. Shareholders are voting on the election of 11 director nominees (all recommended FOR by the Board), an advisory vote to approve named executive officers' compensation (FOR), and ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026 (FOR). Voting must be completed by May 6, 2026, 11:59 PM EDT (May 5 for Retirement Savings Plan shares).

  • ·Virtual meeting access: www.virtualshareholdermeeting.com/LUV2026
  • ·Request proxy materials by April 23, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
  • ·No fee required for filing
Trilogy Metals Inc.DEF 14Aneutralmateriality 4/10

27-03-2026

Trilogy Metals Inc. has filed a definitive proxy statement (DEF 14A) for its Annual Meeting of Shareholders on May 13, 2026, at 10:00 a.m. Vancouver time, where shareholders will receive the audited consolidated financial statements for the fiscal year ended November 30, 2025, elect directors, appoint auditors, and vote on a non-binding advisory resolution approving Named Executive Officer compensation. The record date is March 20, 2026, with 172,545,639 Common Shares outstanding, entitling holders to one vote per share. Proxies must be received by May 11, 2026, at 10:00 a.m. Vancouver time.

  • ·Quorum at the Meeting requires two or more persons representing at least 5% of Common Shares entitled to vote.
  • ·Proxy submission options include delivery to Computershare Toronto office, fax (416-263-9524 or 1-866-249-7775), telephone (1-866-732-8683 or (312) 588-4290), or internet.
  • ·Meeting materials available on company website (www.trilogymetals.com), SEDAR+ (www.sedarplus.ca), and EDGAR (www.sec.gov).
BHAV Acquisition Corp8-Kpositivemateriality 9/10

27-03-2026

BHAV Acquisition Corp, a blank check company, consummated its IPO on March 20, 2026, selling 10,000,000 units at $10.00 per unit, generating $100,000,000 in gross proceeds. Simultaneously, it completed a private placement of 200,000 units at $10.00 per unit to its sponsor BHAV Partners LLC and others, yielding $2,000,000. A total of $100,000,000 was placed in a trust account at $10.00 per unit for public shareholders.

  • ·Total assets as of March 20, 2026: $101,085,982
  • ·Total current liabilities: $223,281 (including $114,381 accrued offering costs and $93,900 over-allotment option liability)
  • ·Shareholders' equity: $862,701 (with accumulated deficit of $113,753)
  • ·Company focuses on business combinations in advanced robotics, EVs, drones, UAS, or fintech sectors
  • ·Sponsor purchased 135,000 private units; at-risk capital investors purchased 65,000
Nurix Therapeutics, Inc.DEFA14Aneutralmateriality 4/10

27-03-2026

Nurix Therapeutics, Inc. filed a Definitive Proxy Statement (DEFA14A) on March 27, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No specific financial metrics, performance data, or other quantitative details are provided in the filing header.

Nurix Therapeutics, Inc.DEF 14Apositivemateriality 8/10

27-03-2026

Nurix Therapeutics' proxy statement features a CEO letter highlighting 2025 clinical advancements, including bexobrutideg's 83.0% ORR, 22.1-month median PFS, and 20.1-month median DOR in heavily pretreated CLL patients from Phase 1a/1b trials, with pivotal DAYBreak-201 Phase 2 and planned DAYBreak-306 Phase 3 studies underway. The company ended FY2025 with $592.9 million in cash, cash equivalents, and marketable securities after a $250.0 million offering, recognized $84.0 million in collaboration revenue from partners like Gilead, Sanofi, and Pfizer, and remains eligible for up to $6.1 billion in future milestones plus royalties. 2026 priorities focus on advancing bexobrutideg to Phase 3 in oncology, expanding into I&I indications, and progressing partnered programs like STAT6 and IRAK4 degraders.

  • ·Annual Meeting scheduled for May 15, 2026 at 9:00 a.m. PT via virtual webcast at www.virtualshareholdermeeting.com/NRIX2026
  • ·Stockholders of record as of March 20, 2026 entitled to vote
  • ·Agenda: Elect three Class III directors for three-year terms; Ratify PricewaterhouseCoopers LLP as independent auditors for FY ending November 30, 2026; Advisory approval of named executive officer compensation
BED BATH & BEYOND, INC.DEFA14Aneutralmateriality 2/10

27-03-2026

Bed Bath & Beyond, Inc. (BBBY-WT) filed a DEFA14A Definitive Additional Proxy Materials on March 27, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing is marked as filed by the registrant with no fee required and contains no substantive proposals, financial data, or additional details in the provided excerpt.

SOUTHWEST AIRLINES CODEF 14Aneutralmateriality 6/10

27-03-2026

Southwest Airlines Co's 2026 DEF 14A Proxy Statement discloses XBRL-tagged executive compensation data for Principal Executive Officers (PEOs) Robert E. Jordan and Gary C. Kelly across 2021-2025, including equity awards, fair value changes, and adjustments for PEO and Non-PEO NEOs. The filing confirms 491,075,748 shares of common stock outstanding as of the March 11, 2026 record date and outlines insider trading policies prohibiting hedging, short sales, pledging, and margin accounts. It also begins disclosure of security ownership for 5%+ beneficial owners as of February 28, 2026.

  • ·Company’s Insider Trading Policy prohibits hedging, monetization transactions, short sales, and derivatives involving Company securities for Directors, officers, Employees, consultants, designees, spouses, and household members.
  • ·Directors and officers prohibited from holding Company securities in margin accounts or pledging as collateral for loans.
  • ·Disclosure of Security Ownership of Certain Beneficial Owners (more than 5% of common stock) as of February 28, 2026.
BED BATH & BEYOND, INC.DEF 14Aneutralmateriality 6/10

27-03-2026

Bed Bath & Beyond's 2026 Proxy Statement outlines Proposal 1 for the election of seven director nominees at the annual meeting: Marcus A. Lemonis (Chairman since 2023, Executive Chairman since 2024, CEO since January 1, 2026), Joanna C. Burkey, Barclay F. Corbus, William B. Nettles, Jr., Debra G. Perelman, Dr. Robert J. Shapiro, and Joseph J. Tabacco, Jr., each to serve until the 2027 annual meeting. The company will engage Georgeson LLC for proxy solicitation services at an anticipated cost of $16,500 plus reimbursements. Proxy materials and the 2025 Form 10-K are available online at investors.beyond.com or by request to Investor Relations.

  • ·Proxy solicitation costs borne by the company, with reimbursements to brokers and use of officers/directors/employees without additional compensation.
  • ·Investor Relations contact: ir@beyond.com or Bed Bath & Beyond, Inc., Attention: Investor Relations, 433 Ascension Way, 3rd Floor, Murray, Utah 84123.
  • ·Proxy solicitor contact: Georgeson LLC at (866) 510-7490.
  • ·Meeting results to be reported in Form 8-K within four business days.
MURPHY OIL CORPDEF 14Amixedmateriality 7/10

27-03-2026

Murphy Oil Corporation's 2026 Proxy Statement highlights strong 2025 operational performance, including average production of 182 MBOEPD (up from 177 MBOEPD in 2024), a 20% year-over-year reduction in LOE/BOE to $10.89, 103% reserve replacement with 715 MMBOE proved reserves, and $1.2B in cash from continuing operations, of which $301.3M was free cash flow with $286M returned to shareholders. Key successes included multiple oil discoveries in Vietnam and the U.S. Gulf of America, alongside financial strengthening via RCF upsizing to $2.00B and $500M notes issuance. However, production growth was modest at approximately 3% YoY, and two of three exploration wells in Côte d’Ivoire delivered non-commercial results.

  • ·U.S. Gulf of America offshore production: 63 MBOEPD in 2025
  • ·Canada offshore production: 7 MBOEPD in 2025
  • ·Vietnam Hai Su Vang resource potential: toward higher end of 170 to 430 MMBOE range
  • ·Acquired 14 blocks in Gulf of America lease sale in December 2025
  • ·Lac Da Vang first oil on track for Q4 2026
  • ·Two non-commercial wells in Côte d’Ivoire three-well exploration program
  • ·Annual meeting scheduled for May 13, 2026
Sportradar Group AG20-Fmixedmateriality 9/10

27-03-2026

Sportradar Group AG reported strong revenue growth of 17% YoY to €1,290M in 2025 from €1,107M in 2024, with Adjusted EBITDA rising 33% to €297M and profit from continuing operations surging to €100M (7.8% margin) from €34M (3.0% margin). However, Customer Net Retention Rate declined to 109% from 127% YoY, signaling potential customer retention challenges, while significant indebtedness requires dedicating material cash flow to debt payments.

  • ·Non-routine litigation costs increased to €35,156k in 2025 from €3,381k in 2024.
  • ·Restructuring costs €6,676k in 2025.
  • ·Transaction-related costs €11,636k and secondary offering costs €2,191k in 2025.
  • ·Significant foreign currency gains of €78,814k in 2025 vs losses of €38,223k in 2024.
  • ·Finance costs rose to €86,531k in 2025 from €78,870k in 2024.
INDIVIOR PLCDEF 14Apositivemateriality 8/10

27-03-2026

Indivior delivered solid 2025 financial results with total net revenue up 4% YoY to $1.24 billion, driven by U.S. SUBLOCADE net revenue growth of 13% to a record $856 million. GAAP net income increased 30x to $210 million from 2024, and Adjusted EBITDA rose 20% YoY to $428 million with a 500 bps margin expansion to 35%. The company completed Phase I of the Indivior Action Agenda, strengthened its balance sheet with 0.7x net leverage, resolved the legacy DOJ matter, and authorized a $400 million share repurchase program, positioning for Phase II acceleration in 2026 ahead of the May 13, 2026 Annual Meeting.

  • ·Annual Meeting: May 13, 2026 at 10:00 a.m. ET (virtual at www.virtualshareholdermeeting.com/INDV2026)
  • ·Record Date: March 18, 2026
  • ·Proposals: Elect 8 directors; Advisory vote on say-on-pay; Advisory vote on say-on-frequency (1 year); Ratify PwC as auditor for FY ending Dec 31, 2026
  • ·Net leverage: 0.7x at year-end 2025
  • ·Resolved legacy DOJ matter
BARNWELL INDUSTRIES INC8-Kneutralmateriality 4/10

27-03-2026

On March 23, 2026, Barnwell Industries, Inc. issued a press release announcing a cash distribution received from its minority partnership interests and providing a corporate update regarding its asset base and value-maximization efforts. The press release is incorporated as Exhibit 99.1. No specific financial figures or performance metrics were detailed in the filing.

  • ·Filing submitted on March 27, 2026, reporting event dated March 23, 2026.
  • ·Company headquarters: 24 Greenway Plaza, Suite 1800Q, Houston, Texas 77046.
Kodiak Sciences Inc.8-Kpositivemateriality 9/10

27-03-2026

Kodiak Sciences Inc. announced positive topline results from GLOW2, its second Phase 3 study in diabetic retinopathy, demonstrating superiority of Zenkuda™ (tarcocimab tedromer) over sham. The press release detailing these results is attached as Exhibit 99.1 and incorporated by reference. The filing was signed by CEO Victor Perlroth, M.D. on March 26, 2026.

  • ·Filing date: March 27, 2026; Date of earliest event: March 26, 2026
  • ·Registrant details: Delaware incorporation, CIK 0001468748, Nasdaq: KOD
  • ·Principal offices: 1250 Page Mill Road, Palo Alto, CA 94304
KKR Enhanced US Direct Lending Fund-L Inc.8-Kpositivemateriality 8/10

27-03-2026

KKR Enhanced US Direct Lending Fund-L Inc., as Collateral Manager, and KKR Enhanced US EVDL Funding LLC, as Borrower, entered into Amendment No. 2 to the Loan and Servicing Agreement dated March 23, 2026, amending the original April 1, 2024 agreement with Citibank, N.A. as Administrative Agent and The Bank of New York Mellon Trust Company, National Association as Collateral Agent. The amendment updates the conformed Loan and Servicing Agreement to provide a secured revolving credit facility of up to U.S.$1,250,000,000 for financing Eligible Collateral Assets. No Events of Default were reported, and all representations and warranties remain true and correct post-amendment.

  • ·Amendment effective upon execution, delivery of good standing certificate, board resolutions, and legal opinion from Dechert LLP.
  • ·Original Loan and Servicing Agreement dated April 1, 2024.
  • ·Governed by New York law.
Oaktree Strategic Credit Fund8-Kmixedmateriality 7/10

27-03-2026

Oaktree Strategic Credit Fund declared a regular March 2026 distribution of $0.1600 gross per share across all common share classes (Class I, D, S, T), with net amounts ranging from $0.1440 to $0.1600 per share, payable on or about April 28, 2026 to shareholders of record as of March 27, 2026. As of February 28, 2026, NAV per share stood at $22.64 across all classes, down approximately 1.0% from $22.87 as of January 31, 2026, while aggregate NAV was approximately $4.7 billion, investment portfolio fair value was $7.3 billion, and outstanding debt principal was $2.9 billion with a net debt-to-equity leverage ratio of 0.57 times. The Fund continues its public offering of up to $5.0 billion and private offering, having issued shares for total consideration of approximately $5.23 billion as of the filing date.

  • ·Net debt-to-equity leverage ratio of approximately 0.57 times as of February 28, 2026.
  • ·Fund publicly offering up to $5.0 billion in shares on a continuous basis.
  • ·Private Offering of unregistered Class I shares pursuant to Section 4(a)(2) and/or Regulation S.
Cyber Enviro-Tech, Inc.8-Kpositivemateriality 8/10

27-03-2026

Cyber Enviro-Tech, Inc. (CETI) entered into an Equity Purchase Agreement with Monroe Street Capital Partners, LP on March 20, 2026, providing the right to sell up to $30,000,000 of common stock over a 24-month Commitment Period, subject to conditions including put notices with minimum $25,000 and maximum $500,000 per put. As consideration, CETI issued 3,000,000 Initial Commitment Shares immediately and agreed to issue additional 3,000,000 Fulfillment Commitment Shares upon each of the first three $2,500,000 gross proceeds milestones. Concurrently, a Registration Rights Agreement requires filing a resale registration statement within 30 days and maintaining its effectiveness.

  • ·Commitment Period: 24 months from March 20, 2026, or earlier termination events.
  • ·Registration Statement filing deadline: within 30 calendar days after March 20, 2026.
  • ·Registration effectiveness target: within 90 calendar days after filing.
  • ·Common Stock trading symbol: CETI on OTCQB.
  • ·Principal Executive Offices: 6991 E. Camelback Road, Suite D-300, Scottsdale, Arizona 85251.
AltEnergy Acquisition Corp8-Kneutralmateriality 7/10

27-03-2026

On March 23, 2026, Michael Salvator resigned as Director (including from Compensation and Audit Committees) and Jonathan Darnell resigned as Chief Financial Officer, both effective immediately and without any disagreements with the Board on operations, policies, or practices. On March 26, 2026, the Board elected Andrew Schoff as Director (to serve on Compensation and Audit Committees) and appointed Andrea Dobi as Chief Financial Officer, both effective immediately. No family relationships, arrangements, or related-party transactions under Item 404(a) of Regulation S-K were disclosed for the new appointees.

  • ·Andrew Schoff, age 44, Founder and CIO of S3 Management LLC; previously Founding Partner at Tide Point Capital, Senior Analyst at Harbor Watch Capital and Diamondback Capital, Associate at Prudential Equity Group; B.A. in Economics from Hamilton College.
  • ·Andrea Dobi, age 52, COO of AltEnergy, LLC since September 2009; previously at J.H. Whitney & Co.; graduated from Fairfield University.
  • ·Company is an emerging growth company.
  • ·Securities trade on OTC Pink Open Market: AEAEU (Units), AEAE (Class A common stock), AEAEW (Warrants).
Cartesian Growth Corp III8-Kneutralmateriality 8/10

27-03-2026

Cartesian Growth Corporation III (CGC), a SPAC, entered into an Amendment to its Business Combination Agreement dated December 17, 2025, with Merger Sub (Fenway MS, Inc.) and Factorial Inc., effective March 26, 2026. The amendments adjust the timing of CGC Shareholder Redemption to occur at least one day prior to Domestication, update definitions including Ancillary Documents, Company Convertible Notes, Required Transaction Proposals, and Nasdaq Proposals, add pre-Domestication actions, and reserve Sections 5.21 and 5.22. No financial terms or impacts are disclosed in the amendment.

  • ·Original Business Combination Agreement dated December 17, 2025
  • ·Amendment governed by New York law with exclusive jurisdiction in New York courts
  • ·Includes updates to Preamble paragraphs regarding Shareholder Redemption and Registration Rights Agreement
BROWN FORMAN CORP8-Kneutralmateriality 9/10

27-03-2026

Brown-Forman Corporation issued a press release on March 26, 2026, regarding a potential business combination involving the Company and Pernod Ricard, furnished as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure). The information is not deemed 'filed' for purposes of Section 18 of the Exchange Act. No financial terms or outcomes of the potential combination were disclosed in the filing.

  • ·Securities registered: Class A Common Stock (BF-A, NYSE), Class B Common Stock (BF-B, NYSE), 1.200% Notes due 2026 (BF26, NYSE), 2.600% Notes due 2028 (BF28, NYSE)
  • ·Filing date: March 27, 2026; Earliest event date: March 26, 2026
Ocugen, Inc.8-Kneutralmateriality 4/10

27-03-2026

Ocugen, Inc. filed a Form 8-K on March 27, 2026, reporting an event on March 26, 2026, under Items 7.01 and 9.01, disclosing an investor presentation (Exhibit 99.1) to be posted on www.ocugen.com for use in discussions with investors and analysts. The presentation includes forward-looking statements under safe harbor provisions and is furnished, not filed, for regulatory purposes. No financial results or operational metrics were detailed in the filing.

  • ·Principal executive office: 11 Great Valley Parkway, Malvern, Pennsylvania 19355
  • ·Securities: Common Stock, $0.01 par value per share (OCGN) on The Nasdaq Capital Market
Traeger, Inc.8-Kmixedmateriality 6/10

27-03-2026

On March 26, 2026, Traeger, Inc.'s Board of Directors reviewed the 2025 annual cash incentive program and determined that performance goals were not achieved, resulting in no payments to the company's named executive officers. Despite this, the Board awarded discretionary cash bonuses of $956,250 to CEO Jeremy Andrus and $270,938 to CFO Michael Joseph (Joey) Hord for their 2025 contributions and to promote retention. No departures, elections, or appointments of directors or officers were reported.

  • ·Event reported on Form 8-K filed March 27, 2026, under Item 5.02 for Compensatory Arrangements of Certain Officers
Totaligent, Inc.8-Kneutralmateriality 7/10

27-03-2026

On March 22, 2026, Totaligent, Inc. entered into an Extension Amendment to its Binding Letter of Intent dated February 22, 2026, with GloMed Solutions Limited Liability Company, extending the target dates for negotiating definitive agreements (including joint venture and IP assignment agreements) and closing the proposed transaction to April 22, 2026. The binding exclusivity period under the LOI is also extended through April 22, 2026. All other terms of the LOI, which outlines a joint venture formation and a call option for Totaligent to acquire GloMed's business, operations, IP, and assets, remain unchanged.

  • ·Original LOI disclosed in 8-K filed February 23, 2026
  • ·Extension Amendment filed as Exhibit 10.1
NEWS CORP8-Kneutralmateriality 4/10

27-03-2026

News Corporation disclosed information provided to the Australian Securities Exchange (ASX) regarding its ongoing stock repurchase program, which authorizes up to $1 billion in aggregate repurchases of Class A and Class B common stock. The disclosures, attached as Exhibits 99.1 and 99.2, are made daily as required by ASX rules if transactions occur and include forward-looking statements about repurchase intentions subject to market conditions and risks. No specific transaction amounts or performance metrics were detailed in the filing.

  • ·Event date: March 26, 2026
  • ·Filing date: March 27, 2026
  • ·Securities: Class A Common Stock (NWSA), Class B Common Stock (NWS) on Nasdaq Global Select Market
DarkPulse, Inc.8-Kneutralmateriality 2/10

27-03-2026

DarkPulse, Inc. filed an 8-K under Item 7.01 Regulation FD Disclosure announcing a live session on X hosted by CEO Dennis O’Leary on March 19, 2026, providing general business discussion and updates. The session is accessible via the provided link on the company's X profile @darkpulsetech. The company emphasizes that the information is summary in nature, not material, and not deemed filed for liability purposes under securities laws.

AMERICAN HONDA FINANCE CORP8-Kpositivemateriality 8/10

27-03-2026

On March 25, 2026, Honda Canada Finance Inc. (HCFI), a subsidiary of American Honda Finance Corp., executed the Second Amendment to its C$2,000,000,000 ($1,455,498,144.20 USD) Third Amended and Restated Credit Agreement, extending the Tranche A commitment termination date from March 25, 2026, to March 25, 2027 (up to C$1,000,000,000 or $727,749,072.12 USD), and Tranche B from March 25, 2027, to March 25, 2029 (up to C$1,000,000,000 or $727,749,072.12 USD). The amendment also permits further extension of Tranche B commitments up to three years upon HCFI request and updates a reference date in Section 8.4 from March 31, 2024, to March 31, 2025. No declines or flat metrics reported; the changes enhance liquidity access.

  • ·Exchange rate used for USD conversions: 1.3741 CAD per USD as of March 23, 2026.
  • ·Amendment filed as Exhibit 10.1.
Public Policy Holding Company, Inc.8-Kneutralmateriality 2/10

27-03-2026

Public Policy Holding Company, Inc. issued a press release on March 23, 2026, incorrectly stating the ex-dividend date for its Common Stock as April 23, 2026 on AIM and April 22, 2026 on Nasdaq. The Company has clarified that the correct ex-dividend date is April 24, 2026 for Common Stock traded on both AIM and Nasdaq. This 8-K filing notes that the information is not deemed 'filed' for purposes of Section 18 of the Exchange Act or incorporated by reference.

Onconetix, Inc.8-Kneutralmateriality 8/10

27-03-2026

Onconetix, Inc. amended its Certificate of Incorporation to implement a 1-for-5 reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on March 25, 2026. Under the amendment, every five shares of old common stock are reclassified into one share of new common stock, with no fractional shares issued and cash payments provided in lieu thereof based on the Nasdaq closing price prior to the effective time. The amendment was duly adopted by the Board of Directors and stockholders in accordance with Delaware law.

  • ·Amendment executed on March 24, 2026.
  • ·Book entry positions for old common stock will be adjusted to reflect new shares post-split.
PetVivo Holdings, Inc.8-K/Apositivemateriality 8/10

27-03-2026

PetVivo Holdings, Inc. entered a Subscription Agreement on March 13, 2026, for $1,000,000 in equity financing in exchange for 1,250,000 units priced at $0.80 per unit, consisting of one restricted common stock share and one warrant each. The company received $400,000 initially on March 13, 2026, with the remaining $600,000 due by April 15, 2026; the investor also holds an option for an additional $1,500,000 investment for 1,875,000 units by June 30, 2026. Warrants are immediately exercisable at $1.10 per share and expire in three years.

  • ·Offering conducted pursuant to Section 4(a)(2) of the Securities Act and Regulation D exemption.
  • ·Investor represented as accredited; securities are restricted under Rule 144 with appropriate legends.
  • ·This is Amendment No. 1 to Form 8-K, date of report March 16, 2026, filed March 27, 2026.
Rumble Inc.8-Kpositivemateriality 8/10

27-03-2026

Rumble Inc. announced that effective March 31, 2026, Mike Masci, formerly VP of Product Management at Intel Corporation, will succeed Brandon Alexandroff as CFO, with Alexandroff transitioning to Strategic Advisor to the CEO. CEO Chris Pavlovski highlighted Masci's expertise in AI, cloud infrastructure, and finance as ideal for scaling Rumble's platform and pursuing AI opportunities from the pending Northern Data acquisition. The announcement underscores continuity with Alexandroff's ongoing involvement.

  • ·Rumble founded in 2013 and headquartered in Longboat Key, Florida.
  • ·Masci previously served as Group CFO of Intel's Datacenter Network Platforms Group and holds a Finance degree from Arizona State University.
Leslie's, Inc.8-Kmixedmateriality 7/10

27-03-2026

Leslie’s, Inc. held its 2026 annual shareholder meeting on March 24, 2026, where shareholders approved the election of three Class II directors (Seth Estep, Lorna Nagler, John Strain) and one Class III director (John Hartmann), ratified Grant Thornton LLP as the independent auditor for the fiscal year ending October 3, 2026, approved executive compensation on an advisory basis, and adopted the Amended and Restated 2020 Omnibus Incentive Plan. However, shareholders rejected proposed amendments to the Certificate of Incorporation to remove and replace supermajority voting requirements.

  • ·Class II Director votes: Seth Estep (4,265,281 For, 565,351 Withheld); Lorna Nagler (4,673,515 For, 157,117 Withheld); John Strain (4,081,977 For, 748,655 Withheld).
  • ·Class III Director votes: John Hartmann (4,700,317 For, 130,315 Withheld).
  • ·Advisory vote on executive compensation: 4,270,495 For, 454,578 Against, 105,559 Abstain.
  • ·Failed Certificate amendments: 4,523,294 For, 205,271 Against, 102,067 Abstain.
  • ·Auditor ratification: 6,575,206 For, 191,295 Against, 1,152 Abstain (no broker non-votes).
Blue Owl Credit Income Corp.8-Kpositivemateriality 9/10

27-03-2026

Blue Owl Credit Income Corp. sold 2,268,562 unregistered Class I common shares for $20,711,969 as of March 2, 2026, pursuant to a private offering exempt under Section 4(a)(2) and Regulation S. Cumulative issuance across public offerings (up to $30B total capacity across Initial, Follow-On, and Current) and private placements reached 2,360,591,146 shares for $22,227,581,726 in total consideration as of March 23, 2026. As of February 28, 2026, the company reported NAV per share of $9.11-$9.13, net leverage of 0.80x, $34.21B par value in debt investments across 347 portfolio companies (87.8% first lien, 98.2% floating rate), $3.90B in liquid Level 2 assets, $0.78B cash, and $16.74B outstanding debt against $23.34B committed capacity.

  • ·Average debt-to-equity leverage ratio of 0.78x for month-to-date period ended February 28, 2026.
  • ·Of $6.69B unsecured fixed rate leverage, $5.84B is hedged by interest rate swaps.
  • ·Top industries by par value: Healthcare providers and services (14.8%), Internet software and services (12.5%), Insurance (8.0%).
Blue Owl Technology Income Corp.8-Kpositivemateriality 7/10

27-03-2026

Blue Owl Technology Income Corp. sold 1,999,419 unregistered Class I common shares for $19,934,210 as of March 2, 2026, pursuant to a private offering exempt under Section 4(a)(2) and Regulation S. The company declared monthly distributions of $0.074775 gross per share for Class S, D, and I shares, with net amounts varying by class after servicing fees, payable through May 2026. As of February 28, 2026, total shares issued across public and private offerings reached 394,453,866 for $4,047,288,147, with a portfolio of $5.1 billion par value across 159 companies (86.9% first lien, 98.1% floating rate debt), net leverage of 0.82x, and $0.9 billion in liquid assets.

  • ·Gross monthly distribution per share: $0.074775 for all classes; net Class S $0.068078, Class D $0.072805, Class I $0.074775 (based on January 31, 2026 NAV).
  • ·Average debt-to-equity leverage ratio month-to-date ended February 28, 2026: 0.88x; net leverage: 0.82x.
  • ·Portfolio industry top holdings by par: Application Software $849,676 (16.4%), Systems Software $713,115 (13.9%), Health Care Technology $608,549 (11.9%).
Luminar Technologies, Inc./DE10-Kmixedmateriality 10/10

27-03-2026

Luminar Technologies reported revenue of $66,014 thousand for the year ended December 31, 2025, down 12% YoY from $75,395 thousand, with Autonomy Solutions declining 24% while ATS grew 15%. Operating expenses fell 47% to $218,583 thousand, improving loss from operations by 32% to $(296,801) thousand, but gross loss worsened 204% to $(78,218) thousand and net loss expanded 34% to $(366,302) thousand amid $46,349 thousand in reorganization items and higher interest expense. Cash and equivalents dropped sharply to $20,259 thousand from $82,840 thousand, with total assets at $131,343 thousand versus $365,213 thousand prior year.

  • ·Total assets declined to $131,343 thousand from $365,213 thousand.
  • ·Stockholders’ deficit worsened to $(476,999) thousand from $(220,789) thousand.
  • ·Reorganization items of $46,349 thousand recognized in 2025.
  • ·Cash flow from investing activities improved to $96,811 thousand from $42,463 thousand.
Apollo Asset Backed Credit Co LLC10-Kmixedmateriality 9/10

27-03-2026

Apollo Asset Backed Credit Co LLC's total assets grew significantly to $1,887,194 as of December 31, 2025 from $296,870 in 2024 (up 536% YoY), driven by investments at fair value surging to $1,577,705 (up 639% YoY) and net assets to $1,612,110 (up 481% YoY). Total investment income rose sharply to $64,943 (up 1,540% YoY) from $3,962, resulting in net investment income of $42,880 and net increase in net assets from operations of $65,052 (up 2,016% YoY). However, cash flows from operating activities deteriorated to $(1,413,805) from $(221,002) (more negative by 540% in magnitude), and net increase in cash declined 53% to $27,594 from $58,585.

  • ·Net asset value per share for A-I Shares averaged $25.52 as of Dec 31, 2025 (up from $25.18).
  • ·Level III assets balance grew to $1,068,004 as of Dec 31, 2025 from $73,377.
  • ·Provision for income taxes totaled $2,267 for year ended Dec 31, 2025.
  • ·Special Purpose Vehicles represent 23.64% of total investments at fair value as of Dec 31, 2025.
BITGO HOLDINGS, INC.10-Kmixedmateriality 9/10

27-03-2026

BitGo Holdings, Inc. reported total revenue of $16,152,121 thousand for the year ended December 31, 2025, up 424% YoY from $3,080,967 thousand in 2024, primarily driven by digital assets sales surging to $15,577,366 thousand. However, the company recorded a net loss of $14,782 thousand compared to a $156,554 thousand profit in 2024, due to a $38,708 thousand net unrealized loss on digital assets and total expenses at nearly 100% of revenue. Adjusted EBITDA improved to a positive $32,411 thousand from $3,227 thousand, reflecting operational leverage despite the net loss.

  • ·Digital assets sales cost was 96.2% of revenue in 2025, up from 82.2% in 2024.
  • ·Gain on disposal of assets was $117,427 thousand in 2024, but only $11,109 thousand in 2025.
  • ·Compensation and benefits expenses grew to $104,171 thousand in 2025 from $79,939 thousand in 2024.
  • ·Filing date: March 27, 2026.
FG Nexus Inc.10-Kmixedmateriality 9/10

27-03-2026

FG Nexus Inc. (FGNXP) reported total assets of $163,844 thousand and stockholders' equity of $143,491 thousand as of December 31, 2025, up significantly from $109,469 thousand and $74,197 thousand in 2024, bolstered by $119,384 thousand in ETH digital assets and higher additional paid-in capital. Total revenue grew 209.8% YoY to $2,413 thousand, driven by new ETH staking rewards of $1,475 thousand and merchant banking advisory fees up to $523 thousand; however, net loss from continuing operations ballooned 178.6% to $67,634 thousand due to $38,327 thousand unrealized loss on ETH digital assets, $14,506 thousand G&A expenses (up 54.4%), and $7,760 thousand stock-based compensation (up 379.6%), while discontinued operations income dropped sharply to $892 thousand from $22,962 thousand.

  • ·Cash used in operating activities from continuing operations: $6,663 thousand in 2025 vs $3,940 thousand in 2024.
  • ·Net cash used in investing activities from continuing operations: $128,147 thousand in 2025 vs provided $13,288 thousand in 2024.
  • ·Net cash provided by financing activities from continuing operations: $136,022 thousand in 2025 vs used $6,856 thousand in 2024.
  • ·Basic and diluted net loss per common share total: $(25.69) in 2025 vs $(12.16) in 2024.
  • ·Weighted average common shares outstanding basic and diluted: 2,667 thousand in 2025 vs 211 thousand in 2024.
Phunware, Inc.10-Kmixedmateriality 9/10

27-03-2026

Phunware's net revenue declined 19.9% YoY to $2,553 thousand in 2025 from $3,189 thousand in 2024, driven by an 78.0% drop in advertising revenue to $282 thousand, although software subscriptions and services grew 19.1% to $2,271 thousand representing 89.0% of total revenue. Gross profit fell 11.2% to $1,291 thousand but gross margin improved to 50.6% from 45.6%; net loss widened to $(11,401) thousand from $(10,316) thousand amid a 42.1% rise in operating expenses to $21,810 thousand. Backlog decreased to $2,275 thousand from $3,635 thousand, while deferred revenue rose slightly to $1,755 thousand.

  • ·Adjusted gross profit declined to $1,353 thousand from $1,633 thousand; adjusted gross margin improved to 53.0% from 51.2%.
  • ·Adjusted EBITDA worsened to $(16,147) thousand from $(10,317) thousand.
  • ·Total backlog and deferred revenue decreased to $4,030 thousand from $5,197 thousand.
  • ·General and administrative expenses rose 46.0% to $15,295 thousand.
SpringBig Holdings, Inc.10-Kmixedmateriality 8/10

27-03-2026

SpringBig Holdings, Inc. reported revenue of $22,834 thousand for the year ended December 31, 2025, down 7.4% from $24,649 thousand in 2024, with net loss widening to $3,247 thousand from $1,876 thousand. The number of retail clients declined 15.3% to 775 from 915, and net revenue retention fell to 79% from 88%, while the number of messages increased 4.7% to 624 million; Adjusted EBITDA decreased 36.1% to $874 thousand from $1,368 thousand. The company highlighted risks including a significant working capital deficiency, history of losses, and challenges in client retention and market expansion.

  • ·Adjustments to EBITDA include stock-based compensation of $481 thousand, credit loss expense of $820 thousand, and severance payments of $808 thousand in 2025.
  • ·2024 EBITDA adjustments included gain on repurchase of convertible debt of $1,573 thousand offset by loss on debt extinguishment of $636 thousand.
Republic Digital Acquisition Co10-Kmixedmateriality 7/10

27-03-2026

Republic Digital Acquisition Co, a blank check company with no operating revenues since inception on January 23, 2025, reported net income of $7,718,712 for the period ended December 31, 2025, driven by $8,077,818 in investment and interest income that offset a $359,106 operating loss from general and administrative costs. The trust account holds $308,053,817 supporting 30,000,000 Class A shares at a redemption value of $10.27 per share, while shareholders' deficit stands at $(11,659,605). Total assets are $309,194,555 with liabilities of $12,800,343, including a $12,720,000 deferred fee.

  • ·Inception date: January 23, 2025
  • ·Class B Ordinary Shares initially issued to Sponsor for $25,000
  • ·Accretion of Class A Ordinary Shares to redemption amount: $(29,200,872)
  • ·Sale of Private Placement Warrants: $7,280,000
  • ·Fair Value of Public Warrants at issuance: $2,700,000
  • ·Allocated value of transaction costs to Class A Ordinary Shares: $(182,445)
  • ·Basic and diluted net income per Class A Ordinary Shares: $0.27
  • ·Basic net income per Class B Ordinary Shares: $0.27
Galata Acquisition Corp. II10-Kmixedmateriality 6/10

27-03-2026

Galata Acquisition Corp. II, a blank check company with no operating history or revenues since inception on June 20, 2025, reported total assets of $175,421,465 as of December 31, 2025, driven by $174,316,692 in the Trust Account from 17,250,000 Class A ordinary shares at a $10.11 per share redemption value. The balance sheet shows a strong liquidity position with $954,585 in cash, but an accumulated deficit of $5,017,682 reflects formation and operating expenses with no offsetting income. Shareholders' deficit stands at $5,017,107 amid potential Working Capital Loans up to $1,500,000 from the Sponsor.

  • ·Redemption value of $10.11 per Class A share
  • ·Inception date: June 20, 2025
  • ·Deferred underwriting fee of $6,037,500
  • ·Prepaid insurance: $70,281 current + $50,564 long-term
Cyngn Inc.10-Kmixedmateriality 9/10

27-03-2026

Cyngn Inc. reported total assets of $50,053,215 as of Dec 31, 2025, up from $30,095,349 in 2024, driven by short-term investments of $33,736,091, while stockholders' equity turned positive at $38,754,406 from a $1,047,916 deficit due to financing proceeds and warrant liability extinguishment. However, revenue declined 40% YoY to $218,976 from $368,138, operating loss widened to $25,688,241 from $22,828,075, cash burned down to $990,023 from $23,617,733, and shares outstanding increased dramatically to 7,974,380 from 199,110, diluting net loss per share to ($5.17) from ($2,521.41). Net loss narrowed to $23,469,273 from $33,335,579 amid higher other income.

  • ·Warrant liability reduced to $0 from $27,703,927, contributing to lower total liabilities.
  • ·R&D expenses increased to $12,468,687 from $11,259,641; G&A to $13,302,781 from $11,400,864.
  • ·Property and equipment, net rose to $3,268,196 from $2,319,402.
  • ·Deferred revenue up to $1,658,015 from $769,180.
Launch Two Acquisition Corp.10-Kmixedmateriality 7/10

27-03-2026

Launch Two Acquisition Corp., a blank check company, reported net income of $8,911,506 for the year ended December 31, 2025, a 302% increase from $2,215,548 for the period from inception (May 13, 2024) through December 31, 2024, primarily driven by $9,820,569 in interest and other income from the Trust Account. However, general and administrative expenses rose 425% to $909,063, leading to an operating loss of the same amount, cash declined 73% to $250,079, and accumulated deficit worsened to $10,747,242. The Trust Account grew 4% to $243,358,236 with redemption value up to $10.58 per share.

  • ·No operating revenues; blank check company with no operating history.
  • ·EPS of $0.31 for redeemable Class A Ordinary Shares in 2025, up from $0.16.
  • ·Risks include potential foreign operations post-Business Combination and repayment of Working Capital Loans.
PMGC Holdings Inc.8-Kneutralmateriality 8/10

27-03-2026

PMGC Holdings Inc.'s wholly-owned subsidiary Northstrive Biosciences Inc. entered into the Third Amendment to its License Agreement with MOA Life Plus Co., Ltd. on March 24, 2026, amending Exhibit C to update development milestones and timelines for the human health field, including pre-clinical studies, IND submission, and Phases 1-3 trials leading to FDA marketing approval (specific timelines redacted). The amendment includes a provision allowing Northstrive to potentially skip the Phase 1 clinical trial for the licensed product BLS-M22 and proceed directly to Phase 2 under certain conditions, with the associated milestone payment combined. As consideration, PMGC must pay a one-time, non-creditable, non-refundable amendment fee (amount redacted) upon execution and within 30 days.

  • ·Original License Agreement dated April 30, 2024; First Amendment in March 2025 expanding field to animal health; Second Amendment on May 12, 2025 clarifying animal health provisions.
  • ·Assignment of original agreement from PMGC to Northstrive on February 28, 2025.
Reliance Global Group, Inc.8-Kpositivemateriality 5/10

27-03-2026

Reliance Global Group, Inc. issued a press release on March 25, 2026, announcing the launch of RELI Exchange 2.0, furnished as Exhibit 99.1 under Regulation FD Disclosure. The filing includes standard company details such as its Florida incorporation, NASDAQ listings for common stock (EZRA, par value $0.086 per share) and Series A Warrants (EZRAW). No financial metrics or performance data were disclosed.

  • ·Securities registered: Common Stock (EZRA, par value $0.086 per share) and Series A Warrants (EZRAW) on The NASDAQ Capital Market.
  • ·Company address: 300 Blvd. of the Americas, Suite 105, Lakewood, New Jersey 08701.
  • ·IRS Employer Identification No.: 46-3390293.
CRH PUBLIC LTD CODEFA14Aneutralmateriality 2/10

27-03-2026

CRH public limited company filed a DEFA14A (Definitive Additional Materials) on March 27, 2026, consisting of a Notice of Internet Availability of proxy statement materials pursuant to Section 14(a) of the Securities Exchange Act of 1934. No filing fee was required. This is a standard proxy solicitation update with no financial or performance data disclosed.

  • ·Filing Type: DEFA14A (Notice of Internet Availability)
KOPIN CORP8-Kmixedmateriality 8/10

27-03-2026

Kopin Corporation reported preliminary Q4 2025 total revenues of $8.4 million, down 42% YoY from $14.6 million, driven by a 56% decline in product revenues to $5.6 million due to government shutdown delays in defense orders and shipments. Non-product revenues increased 47% to $2.5 million, supported by programs like IBAS color MicroLED development. The company strengthened its balance sheet via a $56 million private placement from strategic investors, with cash at $37.8 million, while advancing partnerships with Theon International and maintaining a strong defense pipeline.

  • ·Cost of product revenues was 83% of net product revenues in Q4 2025 vs 84% in Q4 2024, stable due to product mix, quality improvements, cost containment, and automation despite lower volume.
  • ·R&D expenses increased modestly to $3.5 million from $3.1 million, supporting internal technology development including MicroLED advancements.
  • ·SG&A expenses rose to $4.5 million from $3.1 million due to professional fees for capital raise and partnerships.
  • ·Government shutdown impacts expected to continue into Q1 2026.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

🇺🇸 More from United States

View all →
US SEC Filings Daily Market Digest — March 27, 2026 | Gunpowder Blog